Andreas Argyrides

Stock Analyst at Oppenheimer

(1.6)
# 1479
Out of 5,240 analysts
99
Total ratings
43.90%
Success rate
18.97%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
Keros Therapeutics
Maintains: Outperform
102 63
10.42 504.61% 6 Dec 16, 2024
Ascendis Pharma
Reiterates: Outperform
181 181
135 34.07% 9 Nov 15, 2024
Larimar Therapeutics
Initiates Coverage On: Outperform
26
3.43 658.02% 1 Oct 16, 2024
Benitec Biopharma
Initiates Coverage On: Outperform
35
10.32 239.15% 1 Oct 16, 2024
Regulus Therapeutics
Reiterates: Outperform
7 7
1.2 483.33% 1 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
17
1.27 1238.58% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 6 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
104
47.31 119.83% 14 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
5
0.92 443.48% 1 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
0.89 911.24% 7 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
19 19
11.58 64.08% 9 Mar 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 9
3.15 185.71% 4 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
29 29
22.14 30.98% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
21 21
7.36 185.33% 4 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
224 224
120.97 85.17% 4 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
57 57
20.41 179.27% 2 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 6 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 7
1.02 586.27% 3 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
6.09 64.2% 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 10
1.09 817.43% 4 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
73 70
63.73 9.84% 6 Aug 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
53 42
n/a n/a 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Aug 8, 2022